Newsletter: Vol 9, No. 2, December 2025

In this issue, read about progress in our study to validate a medication abortion regimen using ulipristal acetate; evidence and data from Gynuity’s research helping to influence policy and practice decisions both at national and international levels; and the impact of funding cuts on a study assessing a telemedicine care model. Also, read about a special award of recognition presented to the president of Gynuity for contributions to safe abortion access.

Read the full Newsletter